Author

Pantelis K. Vlachos

Observed names: P. Vlachos, Pantelis K Vlachos, Pantelis Vlachos

Observed institution: Carnegie Mellon University

OpenAlex ID: A5010108804

AURIEL ‐PsO: a randomized, double‐blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB 11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis

2019 · J. Hercogová, K.A. Papp, et al. · British Journal of Dermatology · 67

PDF

A simulation-intensive approach for checking hierarchical models

1998 · Dipak K. Dey, Alan E. Gelfand, et al. · Test · 57

Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects

2016 · Elizabeth Hyland, Tim Mant, et al. · British Journal of Clinical Pharmacology · 50

PDF

Detecting Collaborations in Text Comparing the Authors' Rhetorical Language Choices in The Federalist Papers

2003 · Jeff Collins, David Kaufer, et al. · Computers and the Humanities · 44

Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis

2019 · Christopher J. Edwards, Joëlle Monnet, et al. · Clinical Rheumatology · 31

PDF

Chapter 9: Mining Textual Knowledge for Writing Education and Research: The DocuScope Project

2006 · David Kaufer, Cheryl Geisler, et al. · BRILL eBooks · 29

Teaching Language Awareness in Rhetorical Choice

2004 · David Kaufer, Suguru Ishizaki, et al. · Journal of Business and Technical Communication · 14

On the calibration of Bayesian model choice criteria

2002 · Pantelis K Vlachos, Alan E Gelfand · Journal of Statistical Planning and Inference · 14

Hybrid methods for calculating optimal few-stage sequential strategies: Data monitoring for a clinical trial

2002 · Joseph B. Kadane, Pantelis K. Vlachos · Statistics and Computing · 10

Textual Genre Analysis and Identification

2005 · David Kaufer, Cheryl Geisler, et al. · Lecture notes in computer science · 8

Simulation Based Model Checking for Hierarchical Models

2004 · Dipak K. Dey, Alan E. Gelfand, et al. · 7

Fri0088 Safety, Immunogenicity and Efficacy of the Proposed Biosimilar Msb11022 (modified Formulation) Compared With Adalimumab Reference Product in Patients With Moderately to Severely Active Rheumatoid Arthritis: Auriel-ra, a Randomised, Double-blind, Phase Iii Study

2019 · Christopher Edwards, Veronica Chyrok, et al. · Annals of the Rheumatic Diseases · 3

PDF

Pbi35 Quality-of-life Outcomes Comparing the Proposed Biosimilar Msb11022 to Reference Adalimumab in Patients With Moderate-to-severe Chronic Plaque-type Psoriasis

2019 · J. Hercogová, K.A. Papp, et al. · Value in Health · 2

PDF

Nonparametric Bayesian Group Sequential Design

1998 · Pantelis K. Vlachos, Alan E. Gelfand · Lecture notes in statistics · 2

Decision Analysis for a Data Monitoring Committee of a Clinical Trial

1998 · Joseph B. Kadane, Pantelis Vlachos, et al. · Springer eBooks · 2

AB0954 A randomised, double-blind trial comparing the efficacy, safety and immunogenicity of msb11022, a proposed biosimilar of adalimumab, versus adalimumab originator in patients with moderate-to-severe plaque psoriasis

2018 · J. Hercogová, K.A. Papp, et al. · Annals of the Rheumatic Diseases · 1

PDF

Detecting Collaborations in Text

2004 · David S. Kaufer, Pantelis Vlachos, et al. · Dialnet (Universidad de la Rioja)

Nonparametric Bayesian clinical trials design for multivariate patient response

1996 · Pantelis Vlachos · OpenCommons - UConn (University of Connecticut)

Works count: 18

Citation count: 341

H-index: 9

I10-index: 9